Innoviva (INVA) Inventory Average (2013 - 2026)
Innoviva posted quarterly Inventory Average of $39.0 million for Q1 2026, up 3.74% year-on-year from $37.6 million in Q1 2025, and up 0.62% on a QoQ basis from $38.8 million in Q4 2025.
Innoviva (INVA) has 7 years of Inventory Average data on file, last reported at $39.0 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average rose 3.74% year-over-year to $39.0 million; the trailing twelve-month figure through Mar 2026 stood at $39.0 million (up 3.74% YoY), and the FY2025 full-year result was $38.8 million, up 14.09% from the prior year.
- Inventory Average for Q1 2026 stood at $39.0 million, up from $38.8 million in the prior quarter.
- Across five years, Inventory Average topped out at $63.4 million in Q4 2022 and bottomed at $34.0 million in Q4 2024.
- The 5-year median for Inventory Average is $39.9 million (2023), against an average of $42.8 million.
- The widest annual swing landed in 2023, when Inventory Average plunged 35.87%; it then increased 23.21% in 2025.
- A 5-year view of Inventory Average shows it stood at $63.4 million in 2022, then slumped by 35.87% to $40.6 million in 2023, then fell by 16.36% to $34.0 million in 2024, then advanced by 14.09% to $38.8 million in 2025, then advanced by 0.62% to $39.0 million in 2026.
- The last three Inventory Average figures came in at $39.0 million (Q1 2026), $38.8 million (Q4 2025), and $43.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 39.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.01 Mn |
| Dec 31, 2025 | 38.77 Mn |
| Sep 30, 2025 | 43.68 Mn |
| Jun 30, 2025 | 45.24 Mn |
| Mar 31, 2025 | 37.60 Mn |
| Dec 31, 2024 | 33.98 Mn |
| Sep 30, 2024 | 35.45 Mn |
| Jun 30, 2024 | 37.05 Mn |
| Mar 31, 2024 | 39.09 Mn |
| Dec 31, 2023 | 40.63 Mn |
| Sep 30, 2023 | 43.68 Mn |
| Jun 30, 2023 | 48.25 Mn |
| Mar 31, 2023 | 52.78 Mn |
| Dec 31, 2022 | 63.35 Mn |
| Mar 31, 2014 | 10.71 Mn |
| Dec 31, 2013 | 9.72 Mn |
| Sep 30, 2013 | 8.64 Mn |